ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 97 filers reported holding ARATANA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 20.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $426,000 | +153.6% | 82,569 | +77.2% | 0.00% | – |
| Q1 2019 | $168,000 | -91.0% | 46,592 | -84.7% | 0.00% | -100.0% |
| Q4 2018 | $1,863,000 | -31.4% | 303,945 | -34.6% | 0.00% | 0.0% |
| Q3 2018 | $2,715,000 | +28.7% | 464,871 | -6.3% | 0.00% | 0.0% |
| Q2 2018 | $2,110,000 | +20.0% | 496,333 | +24.6% | 0.00% | – |
| Q1 2018 | $1,758,000 | -21.9% | 398,486 | -6.9% | 0.00% | -100.0% |
| Q4 2017 | $2,251,000 | +314.5% | 428,146 | +383.0% | 0.00% | – |
| Q3 2017 | $543,000 | -13.3% | 88,644 | +2.4% | 0.00% | – |
| Q2 2017 | $626,000 | +20.4% | 86,590 | -11.7% | 0.00% | – |
| Q1 2017 | $520,000 | -66.3% | 98,040 | -54.3% | 0.00% | – |
| Q4 2016 | $1,542,000 | +102.9% | 214,642 | +164.2% | 0.00% | – |
| Q3 2016 | $760,000 | +1667.4% | 81,242 | +1087.2% | 0.00% | – |
| Q2 2016 | $43,000 | +22.9% | 6,843 | +9.2% | 0.00% | – |
| Q1 2016 | $35,000 | +105.9% | 6,266 | +103.9% | 0.00% | – |
| Q4 2015 | $17,000 | -29.2% | 3,073 | +7.1% | 0.00% | – |
| Q3 2015 | $24,000 | -99.1% | 2,869 | -98.3% | 0.00% | -100.0% |
| Q2 2015 | $2,554,000 | -30.0% | 168,895 | -25.9% | 0.00% | 0.0% |
| Q1 2015 | $3,649,000 | +60.1% | 227,933 | +78.2% | 0.00% | 0.0% |
| Q4 2014 | $2,279,000 | +1159.1% | 127,925 | +608.2% | 0.00% | – |
| Q3 2014 | $181,000 | +33.1% | 18,063 | +107.7% | 0.00% | – |
| Q2 2014 | $136,000 | +202.2% | 8,696 | +259.5% | 0.00% | – |
| Q1 2014 | $45,000 | +400.0% | 2,419 | +395.7% | 0.00% | – |
| Q4 2013 | $9,000 | – | 488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|